Skip to main content
PMC home page
Human Vaccines & Immunotherapeutics logoLink to Human Vaccines & Immunotherapeutics
. 2022 Jan 11;18(1):2014733. doi: 10.1080/21645515.2021.2014733

HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis

Abdur Rashid a,b, Kang Li b,c, Yi Feng b, Tauseef Ahmad d,✉, Yimam Getaneh b, Yueyang Yu a,b, Xiaoyan Hu a,b, Syed Hani Abidi e, Yiming Shao a,b,✉
PMCID: PMC8973384  PMID: 35016590

ABSTRACT

Background

Despite recent advances in human immunodeficiency virus-1 (HIV-1) prevention, a fast, safe, and effective vaccine will probably be necessary to end the HIV/AIDS pandemic. This study was conducted to evaluate global research trends and map the key bibliometric indices in HIV-1 genetic diversity from 1998 to 2021.

Methods

A comprehensive online search was conducted in the Web of Science Core Collection database to retrieve published literature on HIV-1 genetic diversity. Key bibliometric indicators were calculated and evaluated using HistCiteTM, Bibliometrix: An R-tool, and VOSviewer software for windows.

Results

A total of 2,060 documents written by 9,201 authors and published in 250 journals were included in the final analysis. Year 2012 was the most productive year with 121 (5.87%) publications. The most prolific author was Shao Yiming (n = 74, 3.59%) from Chinese Center for Disease Control and Prevention. The United States of America was the highly contributing and influential country (n = 681, 33.05%). AIDS Research and Human Retroviruses was the most productive journal (n = 562, 27.2%). Network visualization shows that HIV-1 was the most widely used author keyword.

Conclusion

This study provides global research trends and detailed information on HIV-1 genetic diversity. The amount of scientific literature on HIV-1 genetic diversity research has rapidly increased in the last two decades. The maximum number of articles on HIV-1 genetic diversity was published in developed countries; therefore, a scientific research collaboration among researchers and institutes in low-income countries should be promoted and supported.

KEYWORDS: HIV-1, genetic diversity, vaccine, bibliometric analysis, Web of Science Core Collection

Introduction

In the last few decades, human immunodeficiency virus-1 (HIV-1) seriously threatened global public health and disease surveillance systems, particularly in low-income countries. An estimated 37.6 million (30.2–45.0 million) people infected globally were living with HIV-1 in 2020, and 1.5 million (1.1–2.1 million) people were newly infected.1 Despite the availability of HIV-1 antiretroviral drugs, approximately 690,000 (480,000–1 million) people died from acquired immunodeficiency syndrome (AIDS) related illnesses in 2020.1 The currently available antiviral therapy is the only mean to prevent progression of HIV-1 infected patients to AIDS. The development of an effective vaccine is a necessity that may dwindle the need for antiviral therapy.2

HIV-1, like other human RNA viruses, has a high genetic variability that emanates from its high mutation rates,3 retroviral recombination, and high viral turnover.4,5 HIV-1 has been divided into four genetically distinct groups: M, O, N, and P. The vast majority of infections worldwide are caused by group M lineages, which have further diversified into 10 distinct subtypes A, B, C, D, F, G, H, J, K, and L.6–8 Genetic distance within a subtype can be 15 to 20%, whereas genetic distances between subtypes are normally 25 to 35%.3 Recombination between group M subtypes has led to the generation of circulating recombinant forms (CRFs) and unique recombinant forms (URFs).9 Till now, 118 distinct CRFs have been identified globally,10 and these CRFs responsible for 16.7% of all global HIV infections.6

The global HIV-1 genetic diversity is a major stumbling block to the successful design of an effective HIV/AIDS vaccine, as well as antiretroviral therapy, diagnostic and viral load assays.11 Information about country-level HIV-1 diversity help in the successful design of subtype-specific vaccines that can benefit specific countries and regions.12

Bibliometric is the quantitative analysis of scholarly publications concerned about one special topic by statistical and mathematical methods.13 Bibliometric analysis is increasingly used when studying various aspects of science and how worldwide universities and institutions are ranked.14,15 In recent years, the quantity of bibliometric studies in various fields has significantly increased. Several bibliometric studies have been published on HIV/AIDS.16–18 However, to the best of our knowledge, no bibliometric analysis on HIV-1 genetic diversity research has been published to date. Bibliometric analysis of the high number of research publications related to HIV-1 genetic diversity is not only useful providing crucial information for epidemiological assessments and public health interventions, but also to determine future research direction, and new research frontiers. Therefore, in this study we evaluated the global research output and mapped key bibliometric indices in HIV-1 genetic diversity research from 1998 to 2021.

Methods

Study design

The study used a retrospective bibliometric design.

Searching database

On May 15, 2021, the online search was conducted in the Web of Science Core Collection (WoSCC) database hosted by Clarivate Analytics to retrieve scientific publications on HIV-1 genetic diversity from 1998 to May 15, 2021. Web of Science is a comprehensive digital repository of published literature used globally.19

Search strategy and data collection

Two researchers (Abdur Rashid and Kang Li) independently conducted the online search, any disagreements related to inclusion and exclusion were resolved with the help of another researcher (Tauseef Ahmad). The search criteria for the included publications were the following: Topic: (HIV-1 genetic diversity), or Topic: (HIV-1 subtype), or Topic: (HIV-1 CRF), or Topic: (HIV-1 recombinant form), or Topic: (HIV-1 unique recombinant form), or Topic: (HIV-1 second-generation recombinant form), or Topic: (Novel HIV Type 1 recombinant form), or Topic: (HIV-1 genetic diversity and vaccine), or Topic: (HIV-1 genetic diversity impact on vaccine). The search was limited to English language and time span (from 1998 to May 15, 2021). To ensure data accuracy, the titles and abstracts of the published documents were screened carefully. The retrieved data were downloaded in plaintext and CSV format. The following data were extracted from the retrieved documents; title, author name, year of publication, journal, institution, country, and citations count. All the data were retrieved from WoSCC on May 15, 2021, to avoid bias in data collection because the WoSCC database is updated daily.

Data analysis

The obtained data were exported into Microsoft Excel 2019 and the values were presented in frequencies and percentages. The required graphs were generated using GraphPad Prism 8.0 software.

Bibliometric indicators analyses

Various bibliometric indicators, including the number of publications per year, most prolific authors, top journals, most active institutions, countries, frequently used author keywords, and highly cited articles were calculated and evaluated to assess the impact of the published articles using HistCiteTM(http://www.histcite.com/).20 Furthermore, Bibliometrix: An R-tool was used to construct corresponding authors’ countries and wordcloud analysis, and calculate mean total citations per year.21 In addition, the obtained data were plotted for coauthorship countries, author keywords, and cited sources network visualization using VOSviewer software version 1.6.16 for windows (http://www.vosviewer.com).22

Ethical consideration

No ethical approval was required.

Results

The annual quantity of publications

In this study, a total of 2,060 documents published in English language on HIV-1 genetic diversity were analyzed. Majority of the documents were published in the form of original articles (n = 1831, 88.89%) and reviews (n = 98, 4.76%) as shown in Table 1. The changing trend of the annual quantity of publications between 1998 and 2021 is presented in Figure 1. After 1999, growing research productivity was observed, where the highest number of documents (n = 121, 5.87%) were published in 2012, followed by year 2019 (n = 120, 5.82%), while only (n = 22, 1.06%) documents were published in 1998. In the first few months of 2021, (n = 27, 1.31%) documents have been published, which are predicted to rise more in the coming months of the year 2021.

Table 1.

Main information about the retrieved data on HIV-1 genetic diversity from WoSCC database

Description Results
Time span 1998–2021
Countries 125
Journals 263
Documents 2060
References 27556
Document type  
Articles 1831
Reviews 98
Proceedings paper 43
Meetings abstract 36
Letters 26
Editorial materials 11
Early access 10
Corrections 3
Data papers 1
Book chapters 1
Authors collaboration  
Single-authored documents 31
Documents per Author 0.224
Authors per Document 4.47
Coauthors per Documents 8.91
Collaboration Index 4.52
Open in a new tab

Figure 1.

Figure 1.

Open in a new tab

Annual distribution of publications on HIV-1 genetic diversity from 1998- May 15, 2021.

Most active authors

A total of 9,201 authors have been involved in HIV-1 genetic diversity publications. In total, only 184 authors had published at least 10 articles each. Based on number of publications, Shao YM was the most prolific author (n = 74, 3.59%), followed by Peeters M (n = 60, 2.91%), and Feng Y (n = 59, 2.86%) as presented in Table 2. Furthermore, the top 10 authors’ productions over the time as shown in Figure 2.

Table 2.

Top 10 most prolific authors ranked by total number of publications

Rank Author NP Country Affiliation PY_start h_index TC %
1 Shao YM 74 China CDC, China 2000 19 1270 3.59
2 Peeters M 60 France University of Montpellier 1998 30 3053 2.91
3 Feng Y 59 China CDC, China 2004 13 570 2.86
4 McCutchan FE 52 USA Henry M. Jackson Foundation 1998 31 3040 2.52
5 Xing H 49 China CDC, China 2004 16 722 2.37
6 Carr JK 48 USA School of Medicine University of Maryland 1998 26 2266 2.33
7 Li JY 47 China Beijing Institute of Microbiology and Epidemiology 2008 13 473 2.28
8 Bello G 45 Brazil Oswaldo Cruz Institute 2006 16 608 2.18
9 Morgado MG 45 Brazil Oswaldo Cruz Institute 2000 18 962 2.18
10 Delaporte E 43 France University of Montpellier 1998 24 1959 2.08
Open in a new tab

NP: Number of Publications, TC: Total Citations, PY: Publication Year.

Figure 2.

Figure 2.

Open in a new tab

Top 10 most prolific authors’ in HIV-1 genetic diversity.

Most productive journals

The retrieved documents (n = 2,060) were published in 250 journals. In total, only 30 journals published at least 10 articles on HIV-1 genetic diversity. Majority of documents were published in AIDS Research and Human Retroviruses (n = 562, 27.2%), followed by PLoS ONE (n = 156, 7.57%), and AIDS (n = 108, 5.2%). The top 10 journals published 61% of the analyzed documents as shown in Table 3. Among the top 10 most productive journals, the Journal of Clinical Microbiology holds the highest IF 5.345, a Q1 category journal published from the USA. An annual number of publications published by the top 10 listed journals as shown in Figure 3.

Table 3.

Top 10 journals in HIV-1 genetic diversity research

Rank Journal Name NP h_index TC % 2020 IF 5 Year IF JQ Publisher PC
1 AIDS Research and Human Retroviruses 562 40 8477 27.28 2.205 2.096 Q4 Mary Ann Liebert USA
2 PLoS ONE 156 23 2115 7.57 3.24 3.788 Q2 Open Access Scholarly Publisher USA
3 AIDS 108 41 5352 5.24 4.177 4.759 Q3 Wolters Kluwer USA
4 Journal of Virology 91 46 6946 4.41 5.103 5.078 Q1 American Society for Microbiology USA
5 JAIDS-Journal of Acquired Immune Deficiency Syndromes 76 30 2160 3.68 3.731 4.064 Q3 Lippincott USA
6 Journal of Medical Virology 69 19 1115 3.34 2.327 2.075 Q4 Wiley-Blackwell USA
7 Infection Genetics and Evolution 60 15 932 2.91 3.342 3.188 Q3 Elsevier Netherlands
8 Retrovirology 48 18 1080 2.33 4.602 4.199 Q2 BioMed Central England
9 Journal of Clinical Microbiology 41 25 1654 1.99 5.948 5.345 Q1 American Society for Microbiology USA
10 Virology 38 19 1170 1.84 3.616 3.967 Q3 Elsevier USA
Open in a new tab

NP: Number of Publications. TC: Total Citations. IF: Impact Factor. JQ: Journal Quartile. PC: Publisher Country.

Figure 3.

Figure 3.

Open in a new tab

Top 10 journals annual distribution of publications on HIV-1 genetic diversity.

Most active institutions

A total of 2,821 institutions in 125 countries contributed to the articles, and amongst them, only 131 institutions published at least 10 articles on HIV-1 genetic diversity. Institutes that published 30 or more documents have been considered as the most active institutions. The top 10 active institutions, in terms of publishing original articles on HIV-1 genetic diversity, were the Chinese Center for Disease Control and Prevention (n = 78, 3.78%), followed by the Center for Disease Control and Prevention, USA (n = 76, 3.68%), and Walter Reed Army Institute of Research, USA (n = 72, 3.5%) as shown in Table 4.

Table 4.

Top 10 most productive institutions ranked by number of publications

Rank Institution Country NP TC %
1 CDC, China China 78 988 3.78
2 CDC, USA USA 76 2466 3.68
3 Walter Reed Army Institute of Research USA 72 2799 3.49
4 University of Oxford UK 68 3457 3.30
5 Instituto de Salud Carlos | | | Spain 60 1724 2.91
6 Henry M. Jackson Foundation USA 54 4073 2.61
7 National Institute of Infectious Diseases USA 52 1299 2.52
8 Oswaldo Cruz Institute Brazil 50 864 2.42
9 Harvard University USA 50 1505 2.42
10 John Hopkins University USA 49 1874 2.37
Open in a new tab

NP: Number of Publications, CDC: Center for Disease Control and Prevention, TC: Total Citations.

Most active corresponding authors’ countries

A total of 125 countries were found to be involved in HIV-1 genetic diversity research; among them the most productive countries were USA (NP = 681, 33.0%), followed by China (NP = 329, 15.9%), Brazil (NP = 213, 10.3%), and UK (NP = 177, 8.5%). In addition, the USA was the most collaborative country with publications having authors from multiple countries publications (NP = 284), followed by China (NP = 65), and Brazil (NP = 44), as shown in Table 5. The annual distribution of HIV-1 genetic diversity research and the contributions of different countries are presented in Figure 4. The mutual collaboration between the most active corresponding authors’ countries contributed to HIV-1 genetic diversity research is presented in Figure 4.

Table 5.

Top 20 prolific corresponding authors countries and their collaborative publications

Country Total Articles Total citations Average Article Citations Single Country Publications Multiple Country Publications Multiple Country Publications Ratio
USA 486 19,187 39.48 202 284 0.584
CHINA 323 3,161 9.79 258 65 0.201
BRAZIL 181 2,894 15.99 137 44 0.243
FRANCE 115 2,991 26.01 52 63 0.548
SPAIN 94 2,168 23.06 60 34 0.362
ITALY 66 964 14.61 47 19 0.288
JAPAN 62 1,332 21.48 18 44 0.71
UNITED KINGDOM 60 2,597 43.28 29 31 0.517
SOUTH AFRICA 54 892 16.52 18 36 0.667
CANADA 48 1,153 24.02 28 20 0.417
INDIA 43 529 12.3 35 8 0.186
BELGIUM 36 1,286 35.72 8 28 0.778
AUSTRALIA 28 465 16.61 17 11 0.393
GERMANY 26 454 17.46 4 22 0.846
THAILAND 26 707 27.19 10 16 0.615
ARGENTINA 25 325 13 11 14 0.56
SWEDEN 25 659 26.36 11 14 0.56
PORTUGAL 24 542 22.58 10 14 0.583
RUSSIA 23 296 12.87 16 7 0.304
NETHERLANDS 19 401 21.11 9 10 0.526
Open in a new tab

Figure 4.

Figure 4.

Open in a new tab

(a) Corresponding authors’ countries annual distribution of publications. (b) Mutual collaboration between the corresponding authors’ countries in HIV-1 genetic diversity research.

Top 20 highly cited publications

The top 20 highly cited publications on HIV-1 genetic diversity are presented in Table 6. Among the top 20 publications, 17 were research articles, and 3 were review articles. The most highly cited document was a research article ‘‘Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies” published in Journal of Virology by Li M et al., 2005 cited 870 times, followed by ‘‘Timing the ancestor of the HIV-1 pandemic strains’’ published in Science by Korber B et al., 2000 cited 622 times. The top 20 highly cited publications on HIV-1 genetic diversity had citations ranging from 195 to 870.

Table 6.

Top 20 highly cited publications on HIV-1 genetic diversity

Title Journal Document type Date of Publication Corresponding author’s Country Total Citations (TC) Average TC per Year DOI
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies Journal of Virology Article AUG 2005 USA 870 51.1765 10.1128/JVI.79.16.10108–10125.2005
Timing the ancestor of the HIV-1 pandemic strains Science Article JUN 2000 USA 622 28.2727 10.1126/science.288.5472.1789
Global trends in molecular epidemiology of HIV-1 during 2000–2007 AIDS Article MAR 2011 England 520 47.2727 10.1097/QAD.0b013e328342ff93
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing Journal of Virology Article APR 2008 USA 448 32 10.1128/JVI.02660–07
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 AIDS Article OCT 2006 Switzerland 415 25.9375 10.1097/01.aids.0000247564.73009.bc
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm Journal of Virology Article JUL 2009 USA 397 30.5385 10.1128/JVI.00110–09
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 Nature Article OCT 2008 USA 327 23.3571 10.1038/nature07390
The early spread and epidemic ignition of HIV-1 in human populations Science Article OCT 2014 England 288 36 10.1126/science.1256739
Understanding the genetic diversity of HIV-1 AIDS Review 2000 USA 285 12.9545 NA
An African HIV-1 sequence from 1959 and implications for the origin of the epidemic Nature Article FEB 1998 USA 268 11.1667 10.1038/35400
Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000 JAIDS Article FEB 2002 Switzerland 259 12.95 NA
A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant Journal of Virology Article DEC 2000 USA 250 11.3636 10.1128/JVI.74.23.11286–11295.2000
Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID Proceedings of the national academy of sciences of the United States of America Article DEC 2011 USA 246 22.3636 10.1073/pnas.1110064108
Antigenic conservation and immunogenicity Journal of Experimental medicine Article May 2005 USA 241 14.1765 10.1084/jem.20042510
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtypes A and C HIV-1 PLOS PATHOGENS Article JAN 2009 USA 237 18.2308 10.1371/journal.ppat.1000274
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 Journal of Virology Article JUL 1998 USA 237 9.875 10.1128/JVI.72.7.5680–5698.1998
Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Cango suggests that the HIV-1 pandemic originated in Central Africa Journal of Virology Article NOV 2000 France 230 10.4545 10.1128/JVI.74.22.10498–10507.2000
Minireview- Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenic and therapeutic implications Journal of Virology Review OCT 2007 Italy 217 14.4667 10.1128/JVI.00872–07
Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and impact viral RNA levels Journal of Virology Article May 2005 USA 206 12.1176 10.1128/JVI.79.10.6528–6531.2005
Genetic diversity of HIV-1: the moving target AIDS Review 2000 France 195 8.8636 NA
Open in a new tab

Coauthorship countries network visualization

Growing evidence shows that a scientific collaboration network between countries helps admire the countries with potential in the relevant research area.23 The coauthorship countries analysis reflects the degree of collaboration among researchers from different countries based on total link strength. The minimum number of country publications was set at 10, and the number of coauthorship countries per/publication was set at 25. Among the analyzed countries, only 50 countries met the thresholds and formed 9 clusters. The size of each node represents the number of published documents by a country. The USA was the leading country with (TLS = 524), followed by China (TLS = 93), Brazil (TLS = 75), France (TLS = 119), and England (TLS = 141). The USA and China are the most active countries, and both have a high frequency of international collaboration. The thickness of each link represents the strength of collaboration between two countries. The distance between two nodes represents the relatedness of the links they each have.24 Network visualization map of coauthorship countries is shown in Figure 5.

Figure 5.

Figure 5.

Open in a new tab

Coauthorship countries network visualization. Nine clusters between 50 coauthorship countries; Cluster 1 (Countries 14: Belgium, Bulgaria, Denmark, Finland, Greece, India, Israel, Italy, Luxembourg, Mexico, Netherlands, Romania, South Korea, Sweden; Cluster 2 (Countries 8: Burkina Faso, Cameroon, Cote Ivoire, Democratic Republic of Cango, France, Gabon, Republic of Cango, Senegal); Cluster 3 (Countries 6: England, Pakistan, Scotland, Uganda, USA, Zambia); Cluster 4 (Countries 6: Australia, Japan, Malaysia, China, Taiwan, Thailand); Cluster 5 (Countries 5: Angola, Argentina, Brazil, Peru, Portugal); Cluster 6 (Countries 4: Cuba, Russia, Spain, Switzerland); Cluster 7 (Countries 3: Canada, Iran, Kenya); Cluster 8 (Countries 3: Germany, South Africa, Tanzania); Cluster 9 (Countries 1: Nigeria).

Correct the label number...it is Figure 5 not 3

Author keywords network visualization

Before submitting a manuscript to a journal, the author is required to write keywords that reflects the main ideas presented in the article. The keywords analysis provides a medium for discovering key research areas.23 In this context, occurrence shows the number of articles where a keyword occurs, while co-occurrence means how often a keyword occurs with other keywords. Keywords with a strong co-occurrence relationship can divulge research hotspots more accurately than a single keyword. A minimum occurrence of author keywords was set at 10. Among the analyzed keywords, only 62 met the threshold and formed 8 clusters. HIV-1 was the most frequently used author keyword (TLS = 362), followed by HIV (TLS = 160), molecular epidemiology (TLS = 97), subtypes (TLS = 80), and vaccine (TLS = 52). Keywords with the greatest total link strength as shown in Figure 6. The link strength between two keywords is premised on the number of documents both keywords mutually occur, exploring the specific research spot’s relationship. The link’s thickness is proportional to the strength of the link in the network.24 In our visualization analysis, closely connected keywords were colored the same, indicating that they might share something in common. The orange color keywords nodes are related to vaccine research (envelope, evolution, gp120, and diversity). The keywords in red and blue nodes are mainly related to epidemiology. The nodes in purple are related to virology (genotype, protease, mutation, drug resistance, antiretroviral therapy, reverse transcriptase, and AIDS). Wordcloud visualization of frequently used authors’ keywords in the WoSCC database is presented in Figure 6.

Figure 6.

Figure 6.

Open in a new tab

(a) Author keywords co-occurrence network visualization. Eight clusters were formed; Cluster 1: (13 keywords) Cluster 2: (10 keywords), Cluster 3: (9 keywords), Cluster 4: (9 keywords), Cluster 5: (7 keywords), Cluster 6: (6 keywords), Cluster 7: (4 keywords), cluster 8: (4 keywords). (b) Authors’ keywords wordcloud visualization analysis.

Cited sources network visualization

Many studies give attention to the importance of a journal in any scientific field.25 Such analysis helps an author publish their work in a well-reputed journal, and the reader can easily find the best source of information relevant to their work. The obtained data were plotted for cited sources network visualization is shown in Figure 7. The minimum number of citations of a source was set at 30. Among the analyzed sources, only 178 sources met the threshold and formed 4 clusters. AIDS Research and Human Retroviruses journal was the leading journal with (TLS = 7523.8) followed by Journal of Virology (TLS = 7100.08), AIDS (TLS = 6166.73), and Science (TLS = 2302.88).

Figure 7.

Figure 7.

Open in a new tab

Cited sources network visualization. Four clusters were formed; Cluster 1 (sources 66), Cluster 2 (sources 64), Cluster 3 (Sources 29), Cluster 4 (sources 19).

Discussion

HIV-1 unusual degree of genetic variability makes the virus highly heterogenous that has hampered the HIV/AIDS vaccine development.26 This foundation of high genetic variability is the consequence of high replication rates, error-prone reverse transcriptase enzyme, and retroviral recombination that shuttle the mutations between recombinant genomes.27 In the second half of the 20th century, the worldwide transmission of HIV-1 preceded the distinctive distribution of HIV-1 subtypes and recombinants.28

This bibliometric analysis was a solely descriptive analysis of global publications in HIV-1 genetic diversity. Significant research progress has been observed on HIV-1 genetic diversity. The quantity of publications has been steadily increasing over the 24 years study period, particularly since 2000. According to the retrieved documents from WoSCC, most of the research was regarding the epidemiology of HIV-1. Research concerned about the impact of HIV-1 genetic diversity on vaccine development or the consideration of genetic diversity in HIV-1 vaccine development is comparatively less in number since virologists paid less assiduity to this research area. According to the retrieved data, the highly cited document was a research article published by the researcher from Duke University, USA.29 They focus on the priority of broadly neutralizing antibodies for HIV vaccine development. A holy grail of the HIV-1 vaccine field is to elicit broadly neutralizing antibodies. All vaccines try to induce antibodies against the native envelope protein to prevent the virus from infecting host cells, but the HIV-1 envelope is much more devious. Most immunogens were used; none of them give rise to broadly neutralizing antibodies Abs due to lack of consistency in target strains used by scientists. For wide distribution, an extreme need to set up HIV reference strains drawn from a mosaic of HIV-1 variants in order to protect against divergent HIV-1 subtypes and recombinants.29 The second most cited document was an article published by Los Alamos National Laboratory of USA concern about the time estimation of the ancestor sequence of the HIV-1 M group responsible for the HIV pandemic. They estimated HIV-1’s last common ancestor date to be 1931 (1915–1941).30

A total of 125 countries were involved in research on HIV-1 genetic diversity, but most research contributions were from developed countries such as the USA, China, Brazil, and the UK. The USA maintained its leading role in single and multiple countries’ research contributions, followed by China, Brazil, and France, as is also evident from many bibliometric studies in other field.20,21 In the most productive country list, South Africa on the eighth position, which shows their researchers are fostering international collaboration links in HIV/AIDS research, particularly with the USA and UK. The disparities between developed and undeveloped countries can be attributed to treatment and prevention coverage, economic stability, adequate research funding and high international collaboration. AIDS Research and Human Retroviruses was the most prominent and productive journal contributing to HIV-1 genetic diversity research, followed by the Journal of Virology with total citations of 8,477 and 6,946. These top journals are very responsive to new emerging subtypes or recombinants of HIV-1 and with coverage ranging from the molecular basis of the virus to clinical trials on vaccines. All the top 10 journals’ contributions to HIV-1 genetic diversity are stunning and promoted the effective dissemination of pedantic evidence to contend the variability of HIV-1 in developing an HIV-1 vaccine. Shao YM was the most active researcher in the field of HIV-1 genetic diversity research. His research laboratory identified different HIV-1 circulating recombinant forms CRFs among HIV-1 infected Chinese patients and submitted to Los Alamos National Laboratory CRF62_BC,31 CRF64_BC,32 CRF65_cpx,33 CRF79_0107,34 CRF106_cpx.35

Among the most active authors who published more articles on HIV-1 genetic diversity came from the Chinese CDC, French National Research Institute for Sustainable Development (IRD), or Henry M. Jackson Foundation. Most of these authors have collaborated in publishing articles on HIV-1 genetic diversity and belong to the same institutions. The above statement highlights that research collaboration among researchers from different countries needs to be promoted. It is interesting to note that 39.4% of the publications on HIV-1 genetic diversity were collaborative publications. Like other research areas,36–41 the USA was the leading country in HIV-1 genetic research collaboration; the collaborative publications between the USA and China were 3.4%. Compared to developed countries, the collaboration between developing countries was negligible. Chinese institutions research is largely conducted in the area of HIV-1 epidemiology. The majority of highly cited articles research was about HIV-1 vaccine published by the institutions in USA. The country-wise publication pattern indicates that research on HIV-1 diversity in a developing country is very low highlights that research must be supported in developing countries to identify the most common HIV-1 strains circulating that can help in the development of a therapeutic vaccine against prevalent strains in each country.14 The current study might be helpful for researchers to understand the research achievements and trends in HIV-1 genetic diversity. The promotion and sharing of scientific knowledge and medical technologies with developing countries are extremely necessary, which can help to curb the HIV/AIDS in the coming future.

Limitations

The potential limitation of our study lies that the publications related to HIV-1 genetic diversity are only extracted from the WoSCC database; databases like Scopus, PubMed, Google Scholar and Chinese databases were not searched; therefore, the results may be different using other databases. We also evaluated the top cited publications in HIV-1 genetic diversity based on the total citation score. Although, authors have self-citations that can influence the overall number of h-index and citations count.

Conclusion

This study provides global research trends and detailed information on HIV-1 genetic diversity for the first time. The amount of scientific literature on HIV-1 genetic diversity research has rapidly increased in the last two decades. The USA was the leading country in term of publications. Therefore, scientific research in low-income countries should be promoted and supported. The development of an effective HIV-1 vaccine remains a major goal of AIDS research.

Acknowledgments

The authors acknowledge Nankai University and Chinese Center for Disease Control and Prevention CDC for providing online access to the Clarivate Analytics Web of Science Core Collection (WoSCC) database.

Funding Statement

This work was supported by the National Science and Technology Major Project of China [grant number: 2018ZX10731-101], Science Priority [Grant 2019SKLID602] from the State Key Laboratory of Infections Disease Prevention and Control, National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland) [grant number 81861138011].

Disclosure statement

No potential conflict of interest was reported by the author(s).

Authors’ contributions

All the authors potentially contributed and met the authorship criteria.

References

  • 1.Global HIV & AIDS Statistics – 2021 fact sheet . 2021. [accessed 2021 Oct 5]. https://www.unaids.org/en/resources/fact-sheet.
  • 2.Dorrell L. Therapeutic immunization strategies for the control of HIV-1. Expert Rev Vaccines. 2005. Aug;4(4):513–11. doi: 10.1586/14760584.4.4.513. [DOI] [PubMed] [Google Scholar]
  • 3.De Cock KM, Jaffe HW, Curran JW. Reflections on 40 years of AIDS. Emerg Infect Dis. 2021. June;27(6):1553–60. doi: 10.3201/eid2706.210284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019. May;14(3):153–60. doi: 10.1097/COH.0000000000000534. [DOI] [PubMed] [Google Scholar]
  • 5.Thomson MM, Pérez-Alvarez L, Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis. 2002. Aug;2(8):461–71. doi: 10.1016/S1473-3099(02)00343-2. [DOI] [PubMed] [Google Scholar]
  • 6.Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD, Abimiku AG, et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019. Feb;19(2):143–55. doi: 10.1016/S1473-3099(18)30647-9. [DOI] [PubMed] [Google Scholar]
  • 7.German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’., Human Immunodeficiency Virus (HIV). Transfus Med Hemother. 2016. May;43(3):203–22. doi: 10.1159/000445852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.D’Arc M, Ayouba A, Esteban A, Learn GH, Boué V, Liegeois F, Etienne L, Tagg N, Leendertz FH, Boesch C, et al. Origin of the HIV-1 group O epidemic in western lowland gorillas. Proc Natl Acad Sci U S A. 2015. Mar 17;112(11):E1343–52. doi: 10.1073/pnas.1502022112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, et al. HIV-1 nomenclature proposal. Science. 2000. Apr 7;288(5463):55–56. doi: 10.1126/science.288.5463.55d. [DOI] [PubMed] [Google Scholar]
  • 10.Gao Q, Feng Y, Gao L, Zhang M, Liu Y, Xiao M, Dong X, Xia X. Genetic characteristics of a new HIV-1 subtype B/C intersubtype circulating recombinant form (CRF118_BC) identified in Yunnan, China. J Infect. 2021. Aug;83(2):237–79. doi: 10.1016/j.jinf.2021.05.007. [DOI] [PubMed] [Google Scholar]
  • 11.Hemelaar J, Loganathan S, Elangovan R, Yun J, Dickson-Tetteh L, Kirtley S. Country level diversity of the HIV-1 pandemic between 1990 and 2015. J Virol. 2020. Dec 22;95(2). doi: 10.1128/JVI.01580-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Elangovan R, Jenks M, Yun J, Dickson-Tetteh L, Kirtley S, Hemelaar J. Global and regional estimates for subtype-specific therapeutic and prophylactic HIV-1 vaccines: a modeling study. Front Microbiol. 2021;12:690647. doi: 10.3389/fmicb.2021.690647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy. 2015. June;35(6):551–59. doi: 10.1002/phar.1586. [DOI] [PubMed] [Google Scholar]
  • 14.Kawuki J, Yu X, Musa TH. Bibliometric analysis of Ebola research indexed in web of science and scopus (2010-2020). Biomed Res Int. 2020;2020:5476567. doi: 10.1155/2020/5476567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Musa TH, Ahmad T, Li W, Kawuki J, Wana MN, Musa HH, Wei P. A bibliometric analysis of global scientific research on scrub typhus. Biomed Res Int. 2020;2020:5737893. doi: 10.1155/2020/5737893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Macias-Chapula CA. AIDS in Haiti: a bibliometric analysis. Bull Med Libr Assoc. 2000. Jan;88(1):56–61. [PMC free article] [PubMed] [Google Scholar]
  • 17.Uthman OA. HIV/AIDS in Nigeria: a bibliometric analysis. BMC Infect Dis. 2008. Feb 26;8:19. doi: 10.1186/1471-2334-8-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gupta B, Bala A, Kaur H. Mapping of AIDS/HIV research in India: a scientometrics analysis of publications output during 1999–2008. Collnet J Scientometr Inf Manag. 2011;5(2):185–203. doi: 10.1080/09737766.2011.10700912. [DOI] [Google Scholar]
  • 19.Li K, Rollins J, Yan E. Web of science use in published research and review papers 1997-2017: a selective, dynamic, cross-domain, content-based analysis. Scientometrics. 2018;115(1):1–20. doi: 10.1007/s11192-017-2622-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Garfifield E, Paris S, Stock WG. HistCiteTM: a software tool for informetric analysis of citation linkage. Inf Wiss Prax. 2006;57:3911 400. [Google Scholar]
  • 21.Derviş H. Bibliometric analysis using bibliometrix an R package. J Scientometr Res. 2019;8(3):156–60. doi: 10.5530/jscires.8.3.32. [DOI] [Google Scholar]
  • 22.van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38. doi: 10.1007/s11192-009-0146-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Darko A, Chan AP, Huo X, Owusu-Manu D-G. A scientometric analysis and visualization of global green building research. Build Environ. 2019;149:501–11. doi: 10.1016/j.buildenv.2018.12.059. [DOI] [Google Scholar]
  • 24.Van Eck N, Waltman L. Manual for VOSviewer version 1.6. 8. CWTS Meaningful Metrics Universiteit Leiden; 2018.
  • 25.Serenko A. The development of an AI journal ranking based on the revealed preference approach. J Informetr. 2010;4(4):447–59. doi: 10.1016/j.joi.2010.04.001. [DOI] [Google Scholar]
  • 26.Huson MA, Kalkman R, Hoogendijk AJ, Alabi AS, van ‘T Veer C, Grobusch MP, Meijers JCM, van der Poll T. Impact of HIV infection on the haemostatic response during sepsis and malaria. Br J Haematol. 2016. June;173(6):918–26. doi: 10.1111/bjh.14006. [DOI] [PubMed] [Google Scholar]
  • 27.Korber B, Hraber P, Wagh K, Hahn BH. Polyvalent vaccine approaches to combat HIV-1 diversity. Immunol Rev. 2017. Jan;275(1):230–44. doi: 10.1111/imr.12516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol Med. 2012. Mar;18(3):182–92. doi: 10.1016/j.molmed.2011.12.001. [DOI] [PubMed] [Google Scholar]
  • 29.Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol. 2005. Aug;79(16):10108–25. doi: 10.1128/JVI.79.16.10108-10125.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000. June 9;288(5472):1789–96. doi: 10.1126/science.288.5472.1789. [DOI] [PubMed] [Google Scholar]
  • 31.Wei H, His J, Feng Y, Xing H, He X, Liao L, Duan S, Ning C, Wang N, Takebe Y, et al. Identification of a novel HIV-1 circulating recombinant form (CRF62_BC) in western Yunnan of China. AIDS Res Hum Retroviruses. 2014. Apr;30(4):380–83. doi: 10.1089/aid.2013.0235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hsi J, Wei H, Xing H, Feng Y, He X, Liao L, Jia M, Wang N, Ning C, Shao Y, et al. Genome sequence of a novel HIV-1 circulating recombinant form (CRF64_BC) identified from Yunnan, China. AIDS Res Hum Retroviruses. 2014. Apr;30(4):389–93. doi: 10.1089/aid.2013.0234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Feng Y, Wei H, Hsi J, Xing H, He X, Liao L, Ma Y, Ning C, Wang N, Takebe Y, et al. Identification of a novel HIV Type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in Western Yunnan, China. AIDS Res Hum Retroviruses. 2014. June;30(6):598–602. doi: 10.1089/aid.2013.0233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Li Y, Feng Y, Li F, Xue Z, Hu J, Xing H, Ruan Y, Shao Y. Genome sequence of a novel HIV-1 circulating recombinant form (CRF79_0107) identified from Shanxi, China. AIDS Res Hum Retroviruses. 2017. Oct;33(10):1056–60. doi: 10.1089/aid.2017.0066. [DOI] [PubMed] [Google Scholar]
  • 35.Zhou J, Li M, Min C, Ma Y, Shao Y, Xing H. Near full-length genomic characterization of a novel HIV-1 circulating recombinant form (CRF106_cpx) identified among heterosexuals in China. AIDS Res Hum Retroviruses. 2020. Oct;36(10):875–80. doi: 10.1089/aid.2020.0101. [DOI] [PubMed] [Google Scholar]
  • 36.Ahmad T, Haroon, Khan M, Khan M, Murad MA, Baig M, Murtaza BN, Khan MM, Harapan H, Hui J. Research trends in rabies vaccine in the last three decades: a bibliometric analysis of global perspective. Hum Vaccin Immunother. 2021. Sept 2;17(9):3169–77. doi: 10.1080/21645515.2021.1910000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ahmad T, Linlin H, Khan M, Nabi G, Khan S, Çinar IÖ, Haroon, Jalal S, Baig M, Hui J, Xiao-Yan W. Global research trends in pediatric trauma from 1968 to 2021: a bibliometric analysis. Front Pediatr. 2021;9:762531. doi: 10.3389/fped.2021.762531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ahmad T, Murad MA, Nasir S, Musa TH, Baig M, Hui J. Trends in hepatitis A research indexed in the Web of Science: a bibliometric analysis over the period from 1985 to 2019. Hum Vaccin Immunother. 2021;17(9):3221–29. doi: 10.1080/21645515.2021.1914804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shi J, Gao Y, Ming L, Yang K, Sun Y, Chen J, Shi S, Geng J, Li L, Wu J, et al. A bibliometric analysis of global research output on network meta-analysis. BMC Med Inform Decis Mak. 2021;21(1):144. doi: 10.1186/s12911-021-01470-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ahmad T, Murad MA, Baig M, Hui J. Research trends in COVID-19 vaccine: a bibliometric analysis. Hum Vaccin Immunother. 2021;17:2367–72. doi: 10.1080/21645515.2021.1886806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Shah SM, Ahmad T, Chen S, Yuting G, Liu X, Yuan Y. Bibliometric analysis of the one hundred most cited studies in psychosomatic research. Psychother Psychosom. 2021;6:1–6. doi: 10.1159/000516185. [DOI] [PubMed] [Google Scholar]

Articles from Human Vaccines & Immunotherapeutics are provided here courtesy of Taylor & Francis

RESOURCES